Skip to main content

Dengue Fever in Pregnancy



Dengue fever is a viral disease caused by any of four closely related serotypes of flavivirus (RNA virus). Aedes mosquito particularly aedes aegyptii is a vector transmitting it to human beings. Most parts of India are dengue epidemis because of overcrowding and poor sanitation and civic bodies. As cases of adult dengue fever increases after monsoons it also affects pregnant females. The clinical manifestations, treatment and outcome of dengue in pregnant women are similar to those of nonpregnant patients. Few areas of concern shall be briefly touched in this article.

Classical dengue fever is characterized by sudden high fever, severe headache, retro-orbital pain and non specific body aches. Sometimes, ecchymosis or rash develop or bleeding symptoms appear. Dengue infections can sometimes also accompany potentially fatal complications that can cause shock, bleeding or organ damage.  Hence, a pregnant female should always be worked for suspected dengue infection. Misdiagnosis or delayed diagnosis can occur due to overlapping clinical and /or laboratory features with better recognized conditions of pregnancy.

It is still uncertain whether dengue is a significant factor for adverse pregnancy outcomes such as preterm birth, low birth weight and caesarean delivery. Few case reports strongly suggest association of above complications and hence, advise careful monitoring during the course of infection and pregnancy. Women who go into labor while having dengue are at increased risk of heavy bleeding due to thrombocytopenia and may need a platelet transfusion. The risk of vertical transmission is well established among women with dengue infection during the perinatal period. In such cases, the new born should be looked for evidence of congenital dengue infection with evidence of fever, low platelet or a rash. Dengue infection does not warrant a termination of pregnancy. There is also insufficient data of probable embryopathy to mothers who had dengue infection in first trimester.

Management and treatment during pregnancy is quite similar to that of general population. Treatment is mostly symptomatic and to promptly manage the complications. There is also a risk of haemorrhage both for mother and baby when infection occurs near term. Platelet transfusion may be needed in such patients. Blood loss and haemotocrit should be closely watched and promptly intervened to prevent adverse feto-maternal outcome.

To conclude, obstetricians would be frequently encountering dengue infection as the virus is quite epidemic in most parts of India. The treatment and management protocol remains almost same but tight and careful monitoring is warranted for patients near the term. Vertical transmission is well documented but other adverse pregnancy outcome is still controversial.

Author: Dr. Shelly Sehgal , Dr. Dipti Agrawal

Comments

Popular posts from this blog

Diagnosis of Celiac disease

Coeliac disease is an autoimmune disease where the lining of the small intestine is damaged by exposure to gluten (a protein found in grains such as wheat, rye, barley and oats) in genetically predisposed children and adults. The reaction to gluten causes inflammation and atrophy of intestinal lining, which can lead to malabsorption of nutrients and related health issues. The diagnosis of Celiac disease is classically based on a combination of findings from a patient’s clinical history, serologic testing and duodenal biopsies. SEROLOGY TEST: Serologic tests are for screening purposes and do not confirm the diagnosis of coeliac disease. Serologic tests for celiac disease include anti-transglutaminase IgA & IgG antibody, anti-endomysium IgA antibody, and Deamidated Gliadin Peptide IgA & IgG antibodies.  The serologic tests that check for IgA antibodies are more sensitive for celiac disease than the tests for IgG antibodies. However, in people who have IgA deficiency, IgG tests ma

Hepatitis Markers

  Hepatitis means inflammation of the liver. It is commonly the result of a viral infection (hepatitis viruses A, B, C, D, and E), but there are other possible causes of hepatitis like autoimmune hepatitis and hepatitis that occurs as a secondary to medications, drugs, toxins, and alcohol. Hepatitis markers (Antigens, Antibodies & PCR) are useful for determining diagnosis, appropriate treatment, and vaccination status and for monitoring treatment.  Viral Hepatitis Markers: Hepatitis A virus-IgM Antibodies (anti-HAV IgM) : Serum IgM antibody to the hepatitis A virus (antiHAV) appears at about four weeks after initial infection and usually persists for 2-6 months as the initial phase of the immune response. (Test code H018) Hepatitis A virus-IgG Antibodies (anti-HAV IgG) : Serum IgG antibody to HAV generally persists for lifetime, conferring immunity to further HAV infection. (Test code H017) Hepatitis A virus-Total Antibodies (Anti-HAV-Total Ab) : The total HAV antibody test detect

Mucorales RT-PCR: A potential game changer in diagnosis of Mucormycosis

Mucormycosis refers to severe infectious diseases that are caused by filamentous fungi of the Mucorales order that primarily affect immunocompromised patients and patients with diabetes mellitus. Recently, an increasing incidence has been reported among COVID-19 patients in India. The most common genera in invasive mucormycosis are Rhizopus, Rhizomucor, Lichtheimia and Mucor, accounting for 90% of all cases. Clinically and radiographically, mucormycosis is often indistinguishable from other invasive fungal infections such as aspergillosis and remains difficult to diagnose. A definitive diagnosis of mucormycosis typically requires histopathological evidence or positive fungal culture from a specimen from the site of infection, which may be difficult to obtain in some patients. A molecular diagnostic approach, detecting circulating DNA of Mucorales (by PCR) in serum of patients, may help to diagnose invasive mucormycosis more quickly and to introduce directed therapy earlier and eventual

Am